Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norwegian general practice trial of antibiotics for erythema migrans
2010-023747-15Phase 4Completed
- Sponsor
- University of Oslo
- Start
- Nov 2016
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in erythema migrans (EM) and Lyme borreliosis comparing Phenoxymethylpenicillin, Amoxicillin and Doxycycline (3 arms). Primary endpoint: Duration of the rash. Started Nov 2016; status: completed.
02
Drugs
phenoxymethylpenicillinamoxicillindoxycycline
03
Conditions
erythema migrans (EM)Lyme borreliosis
Beyond the preview
Go deeper on 2010-023747-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023747-15.